Issue 000 | U.S. Pilot | US

ATOS

ATOSSA THERAPEUTICS, INC.

Screen state: Passing Source state: Verified 10-Q | 2026-05-08 Filing currency: USD
Internal NCAV Discount 37.5%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
36,668,000USD
Total Liabilities
7,457,000USD
NCAV
29,211,000USD
Cash
31,718,000USD
NCAV per share
3.39USD/share
Evidence
10 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis

Verified split events: reverse 15.0 on 2017-12-31; reverse 12.0 on 2019-12-31; reverse 15.0 on 2026-02-02

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
2018-12-31
10-K
USD
2017-12-31
10-K
USD
2016-12-31
10-K
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -37,141,000 -27,621,000 -31,377,000 -27,691,000 -20,521,000 -14,607,392 -17,265,425 -11,434,233 -7,649,171 -7,968,590
Net Income -34,770,000 -25,504,000 -30,094,000 -26,960,000 -20,606,000 -17,827,952 -17,239,777 -11,404,934 -8,122,581 -6,368,885
Cash From Operations -29,762,000 -21,030,000 -20,941,000 -20,760,000 -16,472,000 -11,570,282 -9,128,442 -8,961,621 -6,593,950 -5,374,589
Capex -23,000 -19,000 -14,000 -27,000 -9,000 -9,367 -7,625 -110,906 n/a n/a
Free Cash Flow -29,785,000 -21,049,000 -20,955,000 -20,787,000 -16,481,000 -11,579,649 -9,136,067 -9,072,527 n/a n/a
Cash And Equivalents 41,299,000 71,084,000 88,460,000 110,890,000 136,377,000 39,553,671 12,581,136 10,380,493 7,217,469 3,027,962
Accounts Receivable n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 45,618,000 74,457,000 92,219,000 118,197,000 141,240,000 42,770,175 14,319,266 11,549,366 7,898,034 3,254,563
Total Assets 47,608,000 76,444,000 96,252,000 123,532,000 141,262,000 42,839,453 14,489,855 11,720,446 8,164,094 4,144,372
Total Current Liabilities 8,255,000 4,967,000 5,236,000 5,568,000 3,126,000 15,671,521 1,322,742 2,915,436 1,225,407 1,047,266
Total Liabilities 8,255,000 4,967,000 5,236,000 5,568,000 3,126,000 15,671,521 1,333,850 2,915,436 1,225,407 1,047,266
Shareholders Equity 39,353,000 71,477,000 91,016,000 117,964,000 138,136,000 27,167,932 13,156,005 8,805,010 6,938,687 3,097,106
Shares Outstanding 8,611,361 8,611,266 8,353,604 8,441,607 8,441,600 8,054,958 608,732 50,647 176,793 1,403
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 8,611,321 8,390,618 8,405,440 8,441,607 7,796,667 753,902 566,464 23,099 64,985 196,485
Weighted Avg Shares Basic 8,611,321 8,390,618 8,405,440 8,441,607 7,796,667 753,902 566,464 23,099 64,985 196,485
Net Share Count Change (Normalized) -0.0% Insufficient evidence 0.0% 0.0% 0.0% 420.7% 1774.1% -81.6% 12505.0% Insufficient evidence
Ownership Claim Change (Normalized) 0.0% Insufficient evidence -0.0% 0.0% -0.0% -80.8% -94.7% 444.3% -99.2% Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -9,870,000 -11,436,000 -9,251,000 -9,040,000 -7,414,000 -7,151,000 -6,385,000 -7,105,000 -6,980,000 -9,018,000 -7,468,000 -7,793,000 -7,098,000 -8,144,000 -8,205,000 -6,595,000 -4,747,000 -4,827,912 -5,158,594 -7,003,766
Net Income -9,589,000 -10,937,000 -8,692,000 -8,423,000 -6,718,000 -6,347,000 -7,230,000 -6,049,000 -5,878,000 -7,754,000 -6,229,000 -9,830,000 -6,281,000 -7,491,000 -8,011,000 -6,672,000 -4,786,000 -4,831,538 -5,197,145 -7,039,248
Cash From Operations -9,581,000 -10,539,000 -6,005,000 -7,259,000 -5,959,000 -7,051,000 -4,750,000 -4,531,000 -4,698,000 -5,571,000 -3,883,000 -4,465,000 -7,022,000 -4,523,000 -5,410,000 -5,949,000 -4,878,000 -3,665,398 -3,061,541 -5,336,273
Capex 0 -7,000 -7,000 0 -9,000 0 -10,000 -3,000 -6,000 0 -1,000 -13,000 0 -8,000 -6,000 0 -13,000 396 -9,396 0
Free Cash Flow -9,581,000 -10,546,000 -6,012,000 -7,259,000 -5,968,000 -7,051,000 -4,760,000 -4,534,000 -4,704,000 -5,571,000 -3,884,000 -4,478,000 -7,022,000 -4,531,000 -5,416,000 -5,949,000 -4,891,000 -3,665,002 -3,070,937 -5,336,273
Cash And Equivalents 31,718,000 41,299,000 51,845,000 57,857,000 65,116,000 71,084,000 74,766,000 79,526,000 83,960,000 88,460,000 94,031,000 99,390,000 103,868,000 110,890,000 117,367,000 125,537,000 131,486,000 136,377,000 140,040,955 142,432,961
Total Current Assets 36,668,000 45,618,000 55,678,000 62,517,000 68,744,000 74,457,000 77,111,000 81,718,000 87,055,000 92,219,000 97,648,000 106,003,000 110,869,000 118,197,000 123,395,000 133,421,000 136,848,000 141,240,000 142,986,884 145,830,918
Total Liabilities 7,457,000 8,255,000 8,225,000 6,820,000 5,425,000 4,967,000 5,796,000 5,696,000 5,328,000 5,236,000 3,444,000 3,478,000 2,944,000 5,568,000 2,868,000 3,792,000 2,322,000 3,126,000 1,675,821 1,796,103
Shares Outstanding 8,611,361 8,611,361 8,611,428 8,611,428 8,611,334 8,611,334 8,386,750 8,383,828 8,383,828 8,353,604 8,353,604 8,385,680 8,441,607 8,441,607 8,441,607 8,441,607 8,441,607 8,441,600 8,441,607 8,441,550
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 8,622,289 8,611,321 8,611,428 8,611,362 8,622,289 8,440,352 8,384,844 8,382,143 8,354,652 8,353,606 8,386,207 8,441,520 8,441,607 8,441,600 8,441,600 8,441,600 8,441,600 116,950,000 8,435,867 8,104,800
Weighted Avg Shares Basic 8,622,289 8,611,321 8,611,428 8,611,362 8,622,289 8,440,352 8,384,844 8,382,143 8,354,652 8,353,606 8,386,207 8,441,520 8,441,607 8,441,600 8,441,600 8,441,600 8,441,600 116,950,000 8,435,867 8,104,800
Net Share Count Change (Normalized) Insufficient evidence -0.0% 0.0% Insufficient evidence Insufficient evidence Insufficient evidence 0.0% Insufficient evidence 0.2% 0.0% -0.9% -0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 164.8%
Ownership Claim Change (Normalized) Insufficient evidence 0.0% 0.0% Insufficient evidence Insufficient evidence Insufficient evidence -0.0% Insufficient evidence -0.2% -0.0% 1.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% -0.0% -0.6% -62.2%
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 36,668,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Total Liabilities 7,457,000USD us-gaap:Liabilities 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Cash 31,718,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Shares Outstanding 8,611,361 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
NCAV 29,211,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 3.39USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 37.5% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001488039
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001488039/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
26
Imported At
2026-08-02T05:40:46+00:00
Rendered At
2026-08-16T03:29:34+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001193125-26-213423
CIK
0001488039
Mary Filing Date
2026-05-08
Filing Currency
USD
Internal Discount
37.5%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-08; mary_accession=0001193125-26-213423; mary_cik=0001488039; gnni_supporting_filing_date=2026-05-08; internal_discount=0.375027; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive